These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28482064)

  • 1. Gut-liver axis and sterile signals in the development of alcoholic liver disease.
    Szabo G; Petrasek J
    Alcohol Alcohol; 2017 Jul; 52(4):414-424. PubMed ID: 28482064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
    Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease.
    Mainz RE; Albers S; Haque M; Sonntag R; Treichel NS; Clavel T; Latz E; Schneider KM; Trautwein C; Otto T
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Alcoholic Liver Disease.
    Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
    Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
    Dong Y; Wu Z; Gai Z; Han M
    J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Hong M; Han DH; Hong J; Kim DJ; Suk KT
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.
    An L; Wirth U; Koch D; Schirren M; Drefs M; Koliogiannis D; Nieß H; Andrassy J; Guba M; Bazhin AV; Werner J; Kühn F
    J Gastrointest Surg; 2022 Mar; 26(3):671-683. PubMed ID: 34734369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
    Albillos A; de Gottardi A; Rescigno M
    J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation.
    Li F; Zhao C; Shao T; Liu Y; Gu Z; Jiang M; Li H; Zhang L; Gillevet PM; Puri P; Deng ZB; Chen SY; Barve S; Gobejishvili L; Vatsalya V; McClain CJ; Feng W
    J Pathol; 2020 Dec; 252(4):371-383. PubMed ID: 33245573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.
    Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(44):16443-51. PubMed ID: 25469012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of ethanol-induced
    Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
    Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
    Maccioni L; Leclercq IA; Schnabl B; Stärkel P
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses.
    Fang C; Du H; Zheng X; Zhao A; Jia W; Xu Y
    FASEB J; 2019 Jun; 33(6):7274-7288. PubMed ID: 30857422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcoholic liver disease: focus on prodromal gut health.
    Park B; Lee HR; Lee YJ
    J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota.
    Ran B; Guo CE; Li W; Li W; Wang Q; Qian J; Li H
    J Sci Food Agric; 2021 May; 101(7):2846-2854. PubMed ID: 33145761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.